52 Week HighNectar Life has hit a 52wk high of Rs 26.00 on NSE
52 Week HighNectar Life has hit a 52wk high of Rs 25.10 on BSE
52 Week HighNectar Life has hit a 52wk high of Rs 23.90 on NSE
52 Week HighNectar Life has hit a 52wk high of Rs 20.90 on NSE
52 Week HighNectar Life has hit a 52wk high of Rs 20.70 on NSE
100% of moneycontrol users recommend buying Nectar Life. What's your call on Nectar Life today? Read 1 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2556.00||0.66||2939.80||1904.15||43,479.83|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|No Mutual Funds Holding the share|
Nectar Life is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 516.92 crore.The company has reported a standalone sales of Rs 391.04 crore and a Net Profit of Rs 17.13 crore for the quarter ended Dec 2013.
The company management includes Sanjiv Goyal - Chairman & Managing Director, Aryan Goyal - Executive Director, H P Singh - Director, Vivek Sett - Director, Vijay J Shah - Independent Director, B K Goswami - Independent Director, S S Chauhan - Independent Director, Raman Kapur - Independent Director, Ajay Swaroop - Independent Director, Dinesh Dua - Wholetime Director & CEO.
It is listed on the BSE with a BSE Code of 532649 and the NSE with an NSE Code of NECLIFE.
Their Registrars are Karvy Computershare Private Ltd.